Cargando…
Cardiovascular manifestations of COVID-19: An evidence-based narrative review
The recent outbreak of coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization on March 11, 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, primarily involves the respiratory system with viral pneumonia as a pr...
Autores principales: | Sharma, Yash Paul, Agstam, Sourabh, Yadav, Ashutosh, Gupta, Anunay, Gupta, Ankur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184068/ https://www.ncbi.nlm.nih.gov/pubmed/33818464 http://dx.doi.org/10.4103/ijmr.IJMR_2450_20 |
Ejemplares similares
-
Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis
por: Agstam, Sourabh, et al.
Publicado: (2020) -
Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020) -
Acute pulmonary embolism: An unseen villain in COVID-19
por: Agstam, Sourabh, et al.
Publicado: (2020) -
Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020) -
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in aortic stenosis - Is this the light at the end of the tunnel for patients with aortic stenosis?
por: Agstam, Sourabh, et al.
Publicado: (2021)